MetLife: CFO Presentation Takeaways

Research evidence excerpt

MetLife: CFO Presentation Takeaways

Deutsche Bank

Research

Rating Company Date

Hold MetLife 11 June 2026

North America Reuters Bloomberg Rating Hold

United States MET.N MET US Price target (USD) 87.00 Price at 10 Jun 26 86.13

52-week range 86.13 – 67.70

Financial

Insurance / Life Valuation & Risks

CFO Presentation Takeaways

Cave Montazeri

Executive Summary Research Analyst

+1-212-250-2798 John McCallion, CFO of MetLife, presented at a conference yesterday, largely

reinforcing prior guidance and the company’s New Frontier framework.

McCallion pointed to a supportive macro backdrop (low unemployment,

manageable inflation, wage growth that is keeping pace, a real estate cycle that

appears to be improving, and broadly stable credit conditions) and to results

tracking at or ahead of the five-year targets laid out in December 2024, which

include double-digit adjusted EPS growth, a 15-17% adjusted ROE ambition, a

100bp reduction in direct expense ratio over five years, and $25 billion-plus of

free cash flow.

Management continues to frame MetLife’s scale and diversification as the core

competitive advantage. McCallion highlighted a roughly balanced mix between

capital-light businesses and balance-sheet businesses, with Group Benefits, Latin

America, EMEA, and asset management on one side, and global retirement

across the U.S., U.K., and Japan on the other. The strategic logic is credible: the

company can compound through higher-ROE, lower-capital-intensity businesses

while still earning attractive spreads where it has balance-sheet and ALM

advantages.

Macro Backdrop and Competitive Positioning

McCallion began with a relatively constructive macro assessment. While

acknowledging uncertainty across jurisdictions, he pointed to several supportive